Back
BMO Low Volatility US Equity Hedged to CAD ETF Vs. Aligos Therapeutics Industry Stock Comparison
Buy
65
ZLH.TO
BMO Low Volatility US Equity Hedged to CAD ETF
Last Price:
$35.09
Seasonality Move:
0.98%
Buy
63
ALGS
Aligos Therapeutics
Last Price:
$8.55
Seasonality Move:
-21.57%
Buy
65
BMO Low Volatility US Equity Hedged to CAD ETF (ZLH.TO)
is a Buy
Is BMO Low Volatility US Equity Hedged to CAD ETF a Buy, Sell or Hold?
-
The current BMO Low Volatility US Equity Hedged to CAD ETF [ZLH.TO] share price is $35.34. The Score for ZLH.TO is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
ZLH.TO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $8.69. The Score for ALGS is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ZLH.TO Stock Price Chart
What is BMO Low Volatility US Equity Hedged to CAD ETF's stock price today?
-
The BMO Low Volatility US Equity Hedged to CAD ETF share price today is $35.34Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZLH.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $8.69Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
ZLH.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.72 | Buy |
Relative Strength Index (14 RSI): | 52.44 | Buy |
Chaikin Money Flow: | 350 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (35.06 - 35.4) | Buy |
Bollinger Bands (100): | (34.78 - 35.82) | Buy |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.47 | Buy |
Relative Strength Index (14 RSI): | 60.92 | Buy |
Chaikin Money Flow: | 37075 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.25 - 8.29) | Buy |
Bollinger Bands (100): | (4.39 - 12.23) | Buy |
ZLH.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.34 | Sell |
20-day SMA: | 35.22 | Buy |
50-day SMA: | 35.19 | Buy |
200-day SMA: | 35.16 | Buy |
8-day EMA: | 25.27 | Buy |
20-day EMA: | 13.91 | Buy |
50-day EMA: | 6.4 | Buy |
200-day EMA: | 1.72 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.17 | Buy |
20-day SMA: | 7.83 | Buy |
50-day SMA: | 6.65 | Buy |
200-day SMA: | 15.18 | Sell |
8-day EMA: | 8.27 | Buy |
20-day EMA: | 7.79 | Buy |
50-day EMA: | 7.66 | Buy |
200-day EMA: | 12.85 | Sell |
BMO Low Volatility US Equity Hedged to CAD ETF Earnings Growth & ZLH.TO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.36 per share, a decrease next quarter of $0.07 per share, an increase this year of $3.67 per share, and a decrease next year of $1.69 per share.
BMO Low Volatility US Equity Hedged to CAD ETF Technical Analysis
Jun 30 | Jul 2 | Jul 3 | Jul 4 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |